{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:13:50Z","timestamp":1789622030087,"version":"build-2803163510"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["733050105"],"award-info":[{"award-number":["733050105"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010969","name":"Alzheimer Nederland","doi-asserted-by":"publisher","award":["14545"],"award-info":[{"award-number":["14545"]}],"id":[{"id":"10.13039\/501100010969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG034389"],"award-info":[{"award-number":["R01AG034389"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS095215"],"award-info":[{"award-number":["R01NS095215"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R56AG064234"],"award-info":[{"award-number":["R56AG064234"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG049704"],"award-info":[{"award-number":["R01AG049704"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX003643"],"award-info":[{"award-number":["I01BX003643"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dysregulation of ceramide and sphingomyelin levels have been suggested to contribute to the pathogenesis of Alzheimer\u2019s disease (AD). Ceramide transfer proteins (CERTs) are ceramide carriers which are crucial for ceramide and sphingomyelin balance in cells. Extracellular forms of CERTs co-localize with amyloid-\u03b2 (A\u03b2) plaques in AD brains. To date, the significance of these observations for the pathophysiology of AD remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A plasmid expressing CERT\n                      <jats:sub>L<\/jats:sub>\n                      , the long isoform of CERTs, was used to study the interaction of CERT\n                      <jats:sub>L<\/jats:sub>\n                      with amyloid precursor protein (APP) by co-immunoprecipitation and immunofluorescence in HEK cells. The recombinant CERT\n                      <jats:sub>L<\/jats:sub>\n                      protein was employed to study interaction of CERT\n                      <jats:sub>L<\/jats:sub>\n                      with amyloid-\u03b2 (A\u03b2), A\u03b2 aggregation process in presence of CERT\n                      <jats:sub>L<\/jats:sub>\n                      , and the resulting changes in A\u03b2 toxicity in neuroblastoma cells. CERT\n                      <jats:sub>L<\/jats:sub>\n                      was overexpressed in neurons by adeno-associated virus (AAV) in a mouse model of familial AD (5xFAD). Ten weeks after transduction, animals were challenged with behavior tests for memory, anxiety, and locomotion. At week 12, brains were investigated for sphingolipid levels by mass spectrometry, plaques, and neuroinflammation by immunohistochemistry, gene expression, and\/or immunoassay.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Here, we report that CERT\n                      <jats:sub>L<\/jats:sub>\n                      binds to APP, modifies A\u03b2 aggregation, and reduces A\u03b2 neurotoxicity in vitro. Furthermore, we show that intracortical injection of AAV, mediating the expression of CERT\n                      <jats:sub>L<\/jats:sub>\n                      , decreases levels of ceramide d18:1\/16:0 and increases sphingomyelin levels in the brain of male 5xFAD mice. CERT\n                      <jats:sub>L<\/jats:sub>\n                      in vivo over-expression has a mild effect on animal locomotion, decreases A\u03b2 formation, and modulates microglia by decreasing their pro-inflammatory phenotype.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Our results demonstrate a crucial role of CERT\n                      <jats:sub>L<\/jats:sub>\n                      in regulating ceramide levels in the brain, in amyloid plaque formation and neuroinflammation, thereby opening research avenues for therapeutic targets of AD and other neurodegenerative diseases.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-021-00780-0","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T13:03:03Z","timestamp":1613653383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["CERTL reduces C16 ceramide, amyloid-\u03b2 levels, and inflammation in a model of Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"13","author":[{"given":"Simone M.","family":"Crivelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo A.A.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Giovagnoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan","family":"van Kruining","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Bode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"den Hoedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Hobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Lena","family":"Scheithauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique T.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Exley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Mold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Mielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga E.","family":"De Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiaan","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L. A.","family":"van den Hove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dusan","family":"Berkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"Ledesma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Verhaagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Losen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhard","family":"Bieberich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5990-3373","authenticated-orcid":false,"given":"Pilar","family":"Martinez-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"issue":"10","key":"780_CR1","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1523\/JNEUROSCI.05-10-02801.1985","volume":"5","author":"J Rogers","year":"1985","unstructured":"Rogers J, Morrison JH. Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer\u2019s disease. J Neurosci. 1985;5(10):2801\u20138.","journal-title":"J Neurosci"},{"issue":"2","key":"780_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/BF00687076","volume":"75","author":"H Kawasaki","year":"1987","unstructured":"Kawasaki H, Murayama S, Tomonaga M, Izumiyama N, Shimada H. Neurofibrillary tangles in human upper cervical ganglia. Morphological study with immunohistochemistry and electron microscopy. Acta Neuropathol. 1987;75(2):156\u20139.","journal-title":"Acta Neuropathol"},{"key":"780_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1749-6632.1982.tb26848.x","volume":"396","author":"HM Wisniewski","year":"1982","unstructured":"Wisniewski HM, Kozlowski PB. Evidence for blood-brain barrier changes in senile dementia of the Alzheimer type (SDAT). Ann N Y Acad Sci. 1982;396:119\u201329.","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"780_CR4","doi-asserted-by":"publisher","first-page":"e60921","DOI":"10.1371\/journal.pone.0060921","volume":"8","author":"G Krabbe","year":"2013","unstructured":"Krabbe G, Halle A, Matyash V, Rinnenthal JL, Eom GD, Bernhardt U, et al. Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS One. 2013;8(4):e60921.","journal-title":"PLoS One"},{"key":"780_CR5","doi-asserted-by":"crossref","unstructured":"Crivelli SM, Giovagnoni C, Visseren L, Scheithauer AL, de Wit N, den Hoedt S, et al. Sphingolipids in Alzheimer\u2019s disease, how can we target them? Adv Drug Deliv Rev. 2020.","DOI":"10.1016\/j.addr.2019.12.003"},{"issue":"2","key":"780_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrm2329","volume":"9","author":"YA Hannun","year":"2008","unstructured":"Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol. 2008;9(2):139\u201350.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"780_CR7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.bbamem.2008.07.030","volume":"1788","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Li X, Becker KA, Gulbins E. Ceramide-enriched membrane domains--structure and function. Biochim Biophys Acta. 2009;1788(1):178\u201383.","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"780_CR8","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1523\/JNEUROSCI.17-09-02929.1997","volume":"17","author":"A Schwarz","year":"1997","unstructured":"Schwarz A, Futerman AH. Distinct roles for ceramide and glucosylceramide at different stages of neuronal growth. J Neurosci. 1997;17(9):2929\u201338.","journal-title":"J Neurosci"},{"issue":"1","key":"780_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1083\/jcb.114.1.155","volume":"114","author":"H Zhang","year":"1991","unstructured":"Zhang H, Desai NN, Olivera A, Seki T, Brooker G, Spiegel S. Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J Cell Biol. 1991;114(1):155\u201367.","journal-title":"J Cell Biol"},{"issue":"Suppl","key":"780_CR10","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1194\/jlr.R800080-JLR200","volume":"50","author":"N Bartke","year":"2009","unstructured":"Bartke N, Hannun YA. Bioactive sphingolipids: metabolism and function. J Lipid Res. 2009;50(Suppl):S91\u20136.","journal-title":"J Lipid Res"},{"issue":"1\u20132","key":"780_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0005-2760(98)00145-3","volume":"1436","author":"DK Perry","year":"1998","unstructured":"Perry DK, Hannun YA. The role of ceramide in cell signaling. Biochim Biophys Acta. 1998;1436(1\u20132):233\u201343.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"780_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1388-1981(00)00054-8","volume":"1486","author":"G van Meer","year":"2000","unstructured":"van Meer G, Holthuis JC. Sphingolipid transport in eukaryotic cells. Biochim Biophys Acta. 2000;1486(1):145\u201370.","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"780_CR13","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1073\/pnas.0305799101","volume":"101","author":"RG Cutler","year":"2004","unstructured":"Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci U S A. 2004;101(7):2070\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"780_CR14","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1212\/WNL.0b013e318264e380","volume":"79","author":"MM Mielke","year":"2012","unstructured":"Mielke MM, Bandaru VV, Haughey NJ, Xia J, Fried LP, Yasar S, et al. Serum ceramides increase the risk of Alzheimer disease: the Women\u2019s Health and Aging Study II. Neurology. 2012;79(7):633\u201341.","journal-title":"Neurology."},{"issue":"3","key":"780_CR15","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.neurobiolaging.2008.05.010","volume":"31","author":"X He","year":"2010","unstructured":"He X, Huang Y, Li B, Gong CX, Schuchman EH. Deregulation of sphingolipid metabolism in Alzheimer\u2019s disease. Neurobiol Aging. 2010;31(3):398\u2013408.","journal-title":"Neurobiol Aging"},{"key":"780_CR16","doi-asserted-by":"crossref","unstructured":"de Wit NM, Snkhchyan H, den Hoedt S, Wattimena D, de Vos R, Mulder MT, et al. Altered sphingolipid balance in capillary cerebral amyloid angiopathy. J Alzheimers Dis. 2016.","DOI":"10.3233\/JAD-160551"},{"issue":"8","key":"780_CR17","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/j.neurobiolaging.2014.02.005","volume":"35","author":"N Fabelo","year":"2014","unstructured":"Fabelo N, Martin V, Marin R, Moreno D, Ferrer I, Diaz M. Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer\u2019s disease and facilitates APP\/BACE1 interactions. Neurobiol Aging. 2014;35(8):1801\u201312.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"780_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1083\/jcb.200307017","volume":"164","author":"JT Lee","year":"2004","unstructured":"Lee JT, Xu J, Lee JM, Ku G, Han X, Yang DI, et al. Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J Cell Biol. 2004;164(1):123\u201331.","journal-title":"J Cell Biol"},{"issue":"1","key":"780_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.nbd.2006.02.010","volume":"23","author":"C Malaplate-Armand","year":"2006","unstructured":"Malaplate-Armand C, Florent-Bechard S, Youssef I, Koziel V, Sponne I, Kriem B, et al. Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway. Neurobiol Dis. 2006;23(1):178\u201389.","journal-title":"Neurobiol Dis"},{"issue":"3","key":"780_CR20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00415-009-5333-x","volume":"257","author":"C Isobe","year":"2010","unstructured":"Isobe C, Abe T, Terayama Y. Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2\u2032-deoxyguanosine in the CSF of patients with Alzheimer\u2019s disease demonstrate that mitochondrial oxidative damage and\/or oxidative DNA damage contributes to the neurodegenerative process. J Neurol. 2010;257(3):399\u2013404.","journal-title":"J Neurol"},{"issue":"22","key":"780_CR21","doi-asserted-by":"publisher","first-page":"19777","DOI":"10.1074\/jbc.M300466200","volume":"278","author":"L Puglielli","year":"2003","unstructured":"Puglielli L, Ellis BC, Saunders AJ, Kovacs DM. Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis. J Biol Chem. 2003;278(22):19777\u201383.","journal-title":"J Biol Chem"},{"issue":"2","key":"780_CR22","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbrc.2014.12.087","volume":"457","author":"N Takasugi","year":"2015","unstructured":"Takasugi N, Sasaki T, Shinohara M, Iwatsubo T, Tomita T. Synthetic ceramide analogues increase amyloid-beta 42 production by modulating gamma-secretase activity. Biochem Biophys Res Commun. 2015;457(2):194\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6968","key":"780_CR23","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nature02188","volume":"426","author":"K Hanada","year":"2003","unstructured":"Hanada K, Kumagai K, Yasuda S, Miura Y, Kawano M, Fukasawa M, et al. Molecular machinery for non-vesicular trafficking of ceramide. Nature. 2003;426(6968):803\u20139.","journal-title":"Nature."},{"issue":"6","key":"780_CR24","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1471-4159.2010.06673.x","volume":"113","author":"C Mencarelli","year":"2010","unstructured":"Mencarelli C, Losen M, Hammels C, De Vry J, Hesselink MK, Steinbusch HW, et al. The ceramide transporter and the Goodpasture antigen binding protein: one protein--one function? J Neurochem. 2010;113(6):1369\u201386.","journal-title":"J Neurochem"},{"issue":"3","key":"780_CR25","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3233\/JAD-161231","volume":"60","author":"SM Crivelli","year":"2017","unstructured":"Crivelli SM, Paulus A, Markus J, Bauwens M, Berkes D, De Vries HE, et al. Synthesis, radiosynthesis, and preliminary in vitro and in vivo evaluation of the fluorinated ceramide trafficking inhibitor (HPA-12) for brain applications. J Alzheimers Dis. 2017;60(3):783\u201394.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"780_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1083\/jcb.200807176","volume":"184","author":"X Wang","year":"2009","unstructured":"Wang X, Rao RP, Kosakowska-Cholody T, Masood MA, Southon E, Zhang H, et al. Mitochondrial degeneration and not apoptosis is the primary cause of embryonic lethality in ceramide transfer protein mutant mice. J Cell Biol. 2009;184(1):143\u201358.","journal-title":"J Cell Biol"},{"issue":"47","key":"780_CR27","doi-asserted-by":"publisher","first-page":"43994","DOI":"10.1074\/jbc.M104884200","volume":"276","author":"S Yasuda","year":"2001","unstructured":"Yasuda S, Kitagawa H, Ueno M, Ishitani H, Fukasawa M, Nishijima M, et al. A novel inhibitor of ceramide trafficking from the endoplasmic reticulum to the site of sphingomyelin synthesis. J Biol Chem. 2001;276(47):43994\u20134002.","journal-title":"J Biol Chem"},{"issue":"2","key":"780_CR28","doi-asserted-by":"publisher","first-page":"e88124","DOI":"10.1371\/journal.pone.0088124","volume":"9","author":"T Yamaji","year":"2014","unstructured":"Yamaji T, Hanada K. Establishment of HeLa cell mutants deficient in sphingolipid-related genes using TALENs. PLoS One. 2014;9(2):e88124.","journal-title":"PLoS One"},{"issue":"18","key":"780_CR29","doi-asserted-by":"publisher","first-page":"14897","DOI":"10.1074\/jbc.M111.299545","volume":"287","author":"C Mencarelli","year":"2012","unstructured":"Mencarelli C, Bode GH, Losen M, Kulharia M, Molenaar PC, Veerhuis R, et al. Goodpasture antigen-binding protein\/ceramide transporter binds to human serum amyloid P-component and is present in brain amyloid plaques. J Biol Chem. 2012;287(18):14897\u2013911.","journal-title":"J Biol Chem"},{"issue":"44","key":"780_CR30","doi-asserted-by":"publisher","first-page":"30246","DOI":"10.1074\/jbc.M805026200","volume":"283","author":"F Revert","year":"2008","unstructured":"Revert F, Ventura I, Martinez-Martinez P, Granero-Molto F, Revert-Ros F, Macias J, et al. Goodpasture antigen-binding protein is a soluble exportable protein that interacts with type IV collagen. Identification of novel membrane-bound isoforms. J Biol Chem. 2008;283(44):30246\u201355.","journal-title":"J Biol Chem"},{"issue":"3","key":"780_CR31","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.4049\/jimmunol.1301673","volume":"192","author":"GH Bode","year":"2014","unstructured":"Bode GH, Losen M, Buurman WA, Veerhuis R, Molenaar PC, Steinbusch HW, et al. Complement activation by ceramide transporter proteins. J Immunol. 2014;192(3):1154\u201361.","journal-title":"J Immunol"},{"issue":"40","key":"780_CR32","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal \u03b2-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129\u201340.","journal-title":"J Neurosci"},{"issue":"8","key":"780_CR33","doi-asserted-by":"publisher","first-page":"5531","DOI":"10.1074\/jbc.M211485200","volume":"278","author":"R Fluhrer","year":"2003","unstructured":"Fluhrer R, Multhaup G, Schlicksupp A, Okochi M, Takeda M, Lammich S, et al. Identification of a beta-secretase activity, which truncates amyloid beta-peptide after its presenilin-dependent generation. J Biol Chem. 2003;278(8):5531\u20138.","journal-title":"J Biol Chem"},{"issue":"4","key":"780_CR34","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/glia.20626","volume":"56","author":"G Wang","year":"2008","unstructured":"Wang G, Silva J, Dasgupta S, Bieberich E. Long-chain ceramide is elevated in presenilin 1 (PS1M146V) mouse brain and induces apoptosis in PS1 astrocytes. Glia. 2008;56(4):449\u201356.","journal-title":"Glia."},{"issue":"3","key":"780_CR35","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3233\/JAD-2004-6310","volume":"6","author":"J Collingwood","year":"2004","unstructured":"House E, Collingwood J, Khan A, Korchazkina O, Berthon G, Exley C. Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of A beta (42) in a manner which may have consequences for metal chelation therapy in Alzheimer\u2019s disease. J Alzheimers Dis. 2004;6(3):291\u2013301.","journal-title":"J Alzheimers Dis"},{"key":"780_CR36","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/srep01256","volume":"3","author":"M Mold","year":"2013","unstructured":"Mold M, Ouro-Gnao L, Wieckowski BM, Exley C. Copper prevents amyloid-beta (1-42) from forming amyloid fibrils under near-physiological conditions in vitro. Sci Rep. 2013;3:1256.","journal-title":"Sci Rep"},{"issue":"1","key":"780_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0042-6822(03)00162-4","volume":"311","author":"S Kugler","year":"2003","unstructured":"Kugler S, Lingor P, Scholl U, Zolotukhin S, Bahr M. Differential transgene expression in brain cells in vivo and in vitro from AAV-2 vectors with small transcriptional control units. Virology. 2003;311(1):89\u201395.","journal-title":"Virology."},{"key":"780_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-7522-8_1","volume":"1715","author":"J Verhaagen","year":"2018","unstructured":"Verhaagen J, Hobo B, Ehlert EME, Eggers R, Korecka JA, Hoyng SA, et al. Small scale production of recombinant adeno-associated viral vectors for gene delivery to the nervous system. Methods Mol Biol. 2018;1715:3\u201317.","journal-title":"Methods Mol Biol"},{"key":"780_CR39","volume-title":"The mouse brain in stereotaxic coordinates","year":"1997","unstructured":"Franklin KB, Paxinos G, editors. The mouse brain in stereotaxic coordinates. San Diego: Academic Press; 1997."},{"issue":"35","key":"780_CR40","doi-asserted-by":"publisher","first-page":"9022","DOI":"10.1523\/JNEUROSCI.5216-05.2006","volume":"26","author":"J Prickaerts","year":"2006","unstructured":"Prickaerts J, Moechars D, Cryns K, Lenaerts I, van Craenendonck H, Goris I, et al. Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. J Neurosci. 2006;26(35):9022\u20139.","journal-title":"J Neurosci"},{"issue":"1","key":"780_CR41","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.neurobiolaging.2012.05.012","volume":"34","author":"AS Sierksma","year":"2013","unstructured":"Sierksma AS, Prickaerts J, Chouliaras L, Rostamian S, Delbroek L, Rutten BP, et al. Behavioral and neurobiological effects of prenatal stress exposure in male and female APPswe\/PS1dE9 mice. Neurobiol Aging. 2013;34(1):319\u201337.","journal-title":"Neurobiol Aging"},{"key":"780_CR42","doi-asserted-by":"crossref","unstructured":"Young K, Morrison H. Quantifying microglia morphology from photomicrographs of immunohistochemistry prepared tissue using ImageJ. J Vis Exp. 2018;136.","DOI":"10.3791\/57648"},{"issue":"9","key":"780_CR43","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/rcm.6216","volume":"26","author":"AU Blachnio-Zabielska","year":"2012","unstructured":"Blachnio-Zabielska AU, Persson XM, Koutsari C, Zabielski P, Jensen MD. A liquid chromatography\/tandem mass spectrometry method for measuring the in vivo incorporation of plasma free fatty acids into intramyocellular ceramides in humans. Rapid Commun Mass Spectrom. 2012;26(9):1134\u201340.","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"11","key":"780_CR44","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1161\/ATVBAHA.119.313246","volume":"39","author":"A Hoogendoorn","year":"2019","unstructured":"Hoogendoorn A, den Hoedt S, Hartman EMJ, Krabbendam-Peters I, Te Lintel HM, van der Zee L, et al. Variation in coronary atherosclerosis severity related to a distinct LDL (low-density lipoprotein) profile: findings from a familial hypercholesterolemia pig model. Arterioscler Thromb Vasc Biol. 2019;39(11):2338\u201352.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"780_CR45","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101\u20138.","journal-title":"Nat Protoc"},{"key":"780_CR46","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-1-60327-223-0_13","volume":"752","author":"SL Gras","year":"2011","unstructured":"Gras SL, Waddington LJ, Goldie KN. Transmission electron microscopy of amyloid fibrils. Methods Mol Biol. 2011;752:197\u2013214.","journal-title":"Methods Mol Biol"},{"issue":"40","key":"780_CR47","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129\u201340.","journal-title":"J Neurosci"},{"issue":"1","key":"780_CR48","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.nbd.2006.12.008","volume":"26","author":"M Ohno","year":"2007","unstructured":"Ohno M, Cole SL, Yasvoina M, Zhao J, Citron M, Berry R, et al. BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP\/PS1 transgenic mice. Neurobiol Dis. 2007;26(1):134\u201345.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"780_CR49","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1471-4159.2010.06608.x","volume":"113","author":"R Kimura","year":"2010","unstructured":"Kimura R, Devi L, Ohno M. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer\u2019s disease transgenic mice. J Neurochem. 2010;113(1):248\u201361.","journal-title":"J Neurochem"},{"issue":"9","key":"780_CR50","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/archneur.59.9.1381","volume":"59","author":"H Fukumoto","year":"2002","unstructured":"Fukumoto H, Cheung BS, Hyman BT, Irizarry MC. Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol. 2002;59(9):1381\u20139.","journal-title":"Arch Neurol"},{"issue":"4","key":"780_CR51","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.celrep.2014.12.041","volume":"10","author":"M Matarin","year":"2015","unstructured":"Matarin M, Salih DA, Yasvoina M, Cummings DM, Guelfi S, Liu W, et al. A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. Cell Rep. 2015;10(4):633\u201344.","journal-title":"Cell Rep"},{"issue":"7","key":"780_CR52","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.2337\/db17-0901","volume":"67","author":"CL Bandet","year":"2018","unstructured":"Bandet CL, Mahfouz R, Veret J, Sotiropoulos A, Poirier M, Giussani P, et al. Ceramide transporter CERT is involved in muscle insulin signaling defects under lipotoxic conditions. Diabetes. 2018;67(7):1258\u201371.","journal-title":"Diabetes."},{"issue":"8","key":"780_CR53","doi-asserted-by":"publisher","first-page":"6488","DOI":"10.1074\/jbc.M409290200","volume":"280","author":"K Kumagai","year":"2005","unstructured":"Kumagai K, Yasuda S, Okemoto K, Nishijima M, Kobayashi S, Hanada K. CERT mediates intermembrane transfer of various molecular species of ceramides. J Biol Chem. 2005;280(8):6488\u201395.","journal-title":"J Biol Chem"},{"issue":"Pt 11","key":"780_CR54","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1242\/jcs.113.11.1857","volume":"113","author":"B De Strooper","year":"2000","unstructured":"De Strooper B, Annaert W. Proteolytic processing and cell biological functions of the amyloid precursor protein. J Cell Sci. 2000;113(Pt 11):1857\u201370.","journal-title":"J Cell Sci"},{"issue":"7","key":"780_CR55","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/hipo.22267","volume":"24","author":"SD Girard","year":"2014","unstructured":"Girard SD, Jacquet M, Baranger K, Migliorati M, Escoffier G, Bernard A, et al. Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer\u2019s disease. Hippocampus. 2014;24(7):762\u201372.","journal-title":"Hippocampus."},{"issue":"16","key":"780_CR56","doi-asserted-by":"publisher","first-page":"6532","DOI":"10.1523\/JNEUROSCI.4586-14.2015","volume":"35","author":"JC Savage","year":"2015","unstructured":"Savage JC, Jay T, Goduni E, Quigley C, Mariani MM, Malm T, et al. Nuclear receptors license phagocytosis by trem2+ myeloid cells in mouse models of Alzheimer\u2019s disease. J Neurosci. 2015;35(16):6532\u201343.","journal-title":"J Neurosci"},{"issue":"22","key":"780_CR57","doi-asserted-by":"publisher","first-page":"20026","DOI":"10.1074\/jbc.M109218200","volume":"277","author":"H Kanazawa","year":"2002","unstructured":"Kanazawa H, Ohsawa K, Sasaki Y, Kohsaka S, Imai Y. Macrophage\/microglia-specific protein Iba1 enhances membrane ruffling and Rac activation via phospholipase C-gamma -dependent pathway. J Biol Chem. 2002;277(22):20026\u201332.","journal-title":"J Biol Chem"},{"issue":"7","key":"780_CR58","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/glia.20967","volume":"58","author":"M Olabarria","year":"2010","unstructured":"Olabarria M, Noristani HN, Verkhratsky A, Rodriguez JJ. Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer\u2019s disease. Glia. 2010;58(7):831\u20138.","journal-title":"Glia."},{"issue":"33","key":"780_CR59","doi-asserted-by":"publisher","first-page":"8653","DOI":"10.1523\/JNEUROSCI.1429-16.2016","volume":"36","author":"MB Dinkins","year":"2016","unstructured":"Dinkins MB, Enasko J, Hernandez C, Wang G, Kong J, Helwa I, et al. Neutral sphingomyelinase-2 deficiency ameliorates Alzheimer\u2019s disease pathology and improves cognition in the 5XFAD mouse. J Neurosci. 2016;36(33):8653\u201367.","journal-title":"J Neurosci"},{"issue":"3","key":"780_CR60","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1074\/jbc.271.3.1613","volume":"271","author":"D Beher","year":"1996","unstructured":"Beher D, Hesse L, Masters CL, Multhaup G. Regulation of amyloid protein precursor (APP) binding to collagen and mapping of the binding sites on APP and collagen type I. J Biol Chem. 1996;271(3):1613\u201320.","journal-title":"J Biol Chem"},{"issue":"3\u20134","key":"780_CR61","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/0300-9084(94)90163-5","volume":"76","author":"G Multhaup","year":"1994","unstructured":"Multhaup G. Identification and regulation of the high affinity binding site of the Alzheimer\u2019s disease amyloid protein precursor (APP) to glycosaminoglycans. Biochimie. 1994;76(3\u20134):304\u201311.","journal-title":"Biochimie."},{"issue":"1","key":"780_CR62","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/jnr.490280109","volume":"28","author":"KC Breen","year":"1991","unstructured":"Breen KC, Bruce M, Anderton BH. Beta amyloid precursor protein mediates neuronal cell-cell and cell-surface adhesion. J Neurosci Res. 1991;28(1):90\u2013100.","journal-title":"J Neurosci Res"},{"issue":"2","key":"780_CR63","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1172\/JCI115625","volume":"89","author":"N Turner","year":"1992","unstructured":"Turner N, Mason PJ, Brown R, Fox M, Povey S, Rees A, et al. Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen. J Clin Invest. 1992;89(2):592\u2013601.","journal-title":"J Clin Invest"},{"issue":"5","key":"780_CR64","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/psc.573","volume":"10","author":"Y Verdier","year":"2004","unstructured":"Verdier Y, Zarandi M, Penke B. Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer\u2019s disease. J Pept Sci. 2004;10(5):229\u201348.","journal-title":"J Pept Sci"},{"issue":"29","key":"780_CR65","doi-asserted-by":"publisher","first-page":"21433","DOI":"10.1074\/jbc.M113.479907","volume":"288","author":"P Ebel","year":"2013","unstructured":"Ebel P, Vom Dorp K, Petrasch-Parwez E, Zlomuzica A, Kinugawa K, Mariani J, et al. Inactivation of ceramide synthase 6 in mice results in an altered sphingolipid metabolism and behavioral abnormalities. J Biol Chem. 2013;288(29):21433\u201347.","journal-title":"J Biol Chem"},{"issue":"48","key":"780_CR66","doi-asserted-by":"publisher","first-page":"33549","DOI":"10.1074\/jbc.M109.031971","volume":"284","author":"S Imgrund","year":"2009","unstructured":"Imgrund S, Hartmann D, Farwanah H, Eckhardt M, Sandhoff R, Degen J, et al. Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and hepatocarcinomas. J Biol Chem. 2009;284(48):33549\u201360.","journal-title":"J Biol Chem"},{"issue":"8","key":"780_CR67","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1089\/hum.2012.052","volume":"23","author":"EA Salegio","year":"2012","unstructured":"Salegio EA, Samaranch L, Jenkins RW, Clarke CJ, Lamarre C, Beyer J, et al. Safety study of adeno-associated virus serotype 2-mediated human acid sphingomyelinase expression in the nonhuman primate brain. Hum Gene Ther. 2012;23(8):891\u2013902.","journal-title":"Hum Gene Ther"},{"issue":"5","key":"780_CR68","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/gbb.12133","volume":"13","author":"TJ Flanigan","year":"2014","unstructured":"Flanigan TJ, Xue Y, Kishan Rao S, Dhanushkodi A, McDonald MP. Abnormal vibrissa-related behavior and loss of barrel field inhibitory neurons in 5xFAD transgenics. Genes Brain Behav. 2014;13(5):488\u2013500.","journal-title":"Genes Brain Behav"},{"issue":"1","key":"780_CR69","doi-asserted-by":"publisher","first-page":"196 e29","DOI":"10.1016\/j.neurobiolaging.2010.05.027","volume":"33","author":"S Jawhar","year":"2012","unstructured":"Jawhar S, Trawicka A, Jenneckens C, Bayer TA, Wirths O. Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer\u2019s disease. Neurobiol Aging. 2012;33(1):196 e29\u201340.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"780_CR70","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/JAD-143120","volume":"45","author":"BC Richard","year":"2015","unstructured":"Richard BC, Kurdakova A, Baches S, Bayer TA, Weggen S, Wirths O. Gene dosage dependent aggravation of the neurological phenotype in the 5XFAD mouse model of Alzheimer\u2019s disease. J Alzheimers Dis. 2015;45(4):1223\u201336.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"780_CR71","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/cns.12809","volume":"24","author":"D Wu","year":"2018","unstructured":"Wu D, Tang X, Gu LH, Li XL, Qi XY, Bai F, et al. LINGO-1 antibody ameliorates myelin impairment and spatial memory deficits in the early stage of 5XFAD mice. CNS Neurosci Ther. 2018;24(5):381\u201393.","journal-title":"CNS Neurosci Ther"},{"key":"780_CR72","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.brainresbull.2017.12.013","volume":"137","author":"L Gu","year":"2018","unstructured":"Gu L, Wu D, Tang X, Qi X, Li X, Bai F, et al. Myelin changes at the early stage of 5XFAD mice. Brain Res Bull. 2018;137:285\u201393.","journal-title":"Brain Res Bull"},{"issue":"4\u20135","key":"780_CR73","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s11064-007-9297-x","volume":"32","author":"P Katsel","year":"2007","unstructured":"Katsel P, Li C, Haroutunian V. Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer\u2019s disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease? Neurochem Res. 2007;32(4\u20135):845\u201356.","journal-title":"Neurochem Res"},{"issue":"2","key":"780_CR74","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3233\/JAD-171054","volume":"63","author":"TA Couttas","year":"2018","unstructured":"Couttas TA, Kain N, Tran C, Chatterton Z, Kwok JB, Don AS. Age-dependent changes to sphingolipid balance in the human hippocampus are gender-specific and may sensitize to neurodegeneration. J Alzheimers Dis. 2018;63(2):503\u201314.","journal-title":"J Alzheimers Dis"},{"key":"780_CR75","doi-asserted-by":"crossref","unstructured":"Han X, D MH, McKeel DW, Jr., Kelley J, Morris JC. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer\u2019s disease: potential role in disease pathogenesis. J Neurochem 2002;82(4):809\u2013818.","DOI":"10.1046\/j.1471-4159.2002.00997.x"},{"key":"780_CR76","doi-asserted-by":"crossref","unstructured":"Barrier L, Fauconneau B, Noel A, Ingrand S. Ceramide and related-sphingolipid levels are not altered in disease-associated brain regions of APP and APP\/PS1 mouse models of Alzheimer\u2019s disease: relationship with the lack of neurodegeneration? Int J Alzheimers Dis. 2011;2011:920958.","DOI":"10.4061\/2011\/920958"},{"issue":"44","key":"780_CR77","doi-asserted-by":"publisher","first-page":"29615","DOI":"10.1074\/jbc.R800019200","volume":"283","author":"G Thinakaran","year":"2008","unstructured":"Thinakaran G, Koo EH. Amyloid precursor protein trafficking, processing, and function. J Biol Chem. 2008;283(44):29615\u20139.","journal-title":"J Biol Chem"},{"issue":"27","key":"780_CR78","doi-asserted-by":"publisher","first-page":"25811","DOI":"10.1074\/jbc.M412052200","volume":"280","author":"I Lopez-Montero","year":"2005","unstructured":"Lopez-Montero I, Rodriguez N, Cribier S, Pohl A, Velez M, Devaux PF. Rapid transbilayer movement of ceramides in phospholipid vesicles and in human erythrocytes. J Biol Chem. 2005;280(27):25811\u20139.","journal-title":"J Biol Chem"},{"issue":"2","key":"780_CR79","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/09687860500439474","volume":"23","author":"L Silva","year":"2006","unstructured":"Silva L, de Almeida RF, Fedorov A, Matos AP, Prieto M. Ceramide-platform formation and -induced biophysical changes in a fluid phospholipid membrane. Mol Membr Biol. 2006;23(2):137\u201348.","journal-title":"Mol Membr Biol"},{"issue":"6","key":"780_CR80","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","volume":"16","author":"FL Heppner","year":"2015","unstructured":"Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci. 2015;16(6):358\u201372.","journal-title":"Nat Rev Neurosci"},{"issue":"25","key":"780_CR81","doi-asserted-by":"publisher","first-page":"21384","DOI":"10.1074\/jbc.M112.340513","volume":"287","author":"G Wang","year":"2012","unstructured":"Wang G, Dinkins M, He Q, Zhu G, Poirier C, Campbell A, et al. Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD). J Biol Chem. 2012;287(25):21384\u201395.","journal-title":"J Biol Chem"},{"issue":"8","key":"780_CR82","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.neurobiolaging.2014.02.012","volume":"35","author":"MB Dinkins","year":"2014","unstructured":"Dinkins MB, Dasgupta S, Wang G, Zhu G, Bieberich E. Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer\u2019s disease. Neurobiol Aging. 2014;35(8):1792\u2013800.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"780_CR83","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12974-019-1436-1","volume":"16","author":"NM de Wit","year":"2019","unstructured":"de Wit NM, den Hoedt S, Martinez-Martinez P, Rozemuller AJ, Mulder MT, de Vries HE. Astrocytic ceramide as possible indicator of neuroinflammation. J Neuroinflammation. 2019;16(1):48.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"780_CR84","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40478-020-00931-8","volume":"8","author":"A Elsherbini","year":"2020","unstructured":"Elsherbini A, Kirov AS, Dinkins MB, Wang G, Qin H, Zhu Z, et al. Association of Abeta with ceramide-enriched astrosomes mediates Abeta neurotoxicity. Acta Neuropathol Commun. 2020;8(1):60.","journal-title":"Acta Neuropathol Commun"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00780-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13195-021-00780-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00780-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T08:00:24Z","timestamp":1724486424000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-021-00780-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["780"],"URL":"https:\/\/doi.org\/10.1186\/s13195-021-00780-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-33901\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-42740\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-42740\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-42740\/v3","asserted-by":"object"}]},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]},"assertion":[{"value":"10 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments were approved by the Animal Welfare Committee of Maastricht University (project number DEC2013-056 and DEC2015-002) and followed the laws, rules, and guidelines of the Netherlands.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}